Howard Kartstein

Howard Kartstein has a diverse work experience in the field of business development. Howard is currently the Director of Business Development at Certis Oncology Solutions, Inc., where they focus on the development of orthotopic patient-derived xenograft (O-PDX) models. Prior to this, they served as the Director of Business Development at GeneCentric Therapeutics, Inc. where they were responsible for business development efforts.

Before that, Howard worked as a Senior Business Development Manager at Owlstone Medical. Howard also has experience as a Sales Executive and Director of Business Development for Precision Medicine at Metabolon, Inc. Additionally, they worked as the Director of Business Development for Discovery Services, North America at Eurofins Pharma Discovery Services.

Howard has held several roles in their career, including Business Manager, East at Second Genome, Inc., Director of Business Development at Gentronix Limited, Director of Business Development at Eurofins Cerep Panlabs, and Director of Sales/Business Development Director, North America at Metabolon.

Their extensive work experience showcases their expertise in business development and their ability to drive growth in various organizations within the healthcare and life sciences industry.

Howard Kartstein attended the University of New Hampshire from 1979 to 1983, where they obtained a Bachelor of Science degree in Microbiology.